Prensky Zachary

DirectorLB PHARMACEUTICALS INC (LBRX) · full profile →Form 4 · filed Sep 12, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
11
0 non-derivative · 11 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 10, 2025Disposed to issuer(D)8960
Sep 10, 2025Grant(A)54K54K
Sep 10, 2025Grant(A)4K4K
Sep 10, 2025Disposed to issuer(D)4K0
Sep 10, 2025Grant(A)22K$022K
Sep 10, 2025Grant(A)896896
Sep 10, 2025Disposed to issuer(D)54K0
Sep 10, 2025Grant(A)18K18K
Sep 10, 2025Disposed to issuer(D)18K0
Sep 10, 2025Grant(A)1K1K
Sep 10, 2025Disposed to issuer(D)1K0

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-024448) within minutes of acceptance. Every field above traces to the original document. Verify it directly: